Precision Biosensor enters Italy with chemical test kits

South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Chemical Inc. for its clinical chemistry kits for human diagnoses.

The sales contract added Italy to the list of its European export markets after Germany and Romania, Precision said on Thursday.

Under the export contract, Prevision Biosensor will ship 300 units of the in vitro testing devices Exdia PT10S or more for the next three years. In addition, it will sell more than 75,000 units of five types of cartridges during the same period.

The export value was not immediately disclosed.

The Exdia PT1OS is designed for clinical chemical tests. Blood or other body fluids are spilled on five-type cartridges for body composition analyses, using either chemical or biochemical methods.

In Italy, pharmacies are permitted to sell self-testing kits such as the Exdia PT1OS for primary diagnoses of cholesterol and neutral fat. Pharmacies in the European country also offer medical reservation services and physical therapies.

Italy is the third-largest in vitro diagnostic device market in Europe.

In July of last year, the Kosdaq-listed company signed a 118.2 billion won ($90 millio) contract with a US company to export its chemical diagnostic products for animals. This marked its first sales contract with a US firm.

Precision is now preparing to win approval for its chemical test kits for human diagnoses in the US.

Write to Jeong-Min Nam at peux@hankyung.com
Yeonhee Kim edited this article